Efficacy Study of Autosuggestion for Quality of Life of Geriatric Patients
NCT ID: NCT01681056
Last Updated: 2012-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2010-08-31
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of this study is that autosuggestion will increase geriatric patient's quality of life based on its impact to psycho-neuro-endocrine-immune pathways.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
THE EFFECT OF EXERGAMING APPLICATION AND AUTOGENIC RELAXATION TECHNIQUE ON PSYCHOLOGICAL WELL-BEING AND LIFE ENGAGEMENT OF NURSING HOME RESIDENTS: A RANDOMİZED CONTROLLED TRİAL
NCT06965959
Non-invasive Stimulation Through Nesa and Therapeutic Exercise on Sleep Disturbances on Alzheimer's Disease Patients.
NCT05715866
Evaluation of the Effect of Memory-based Reminiscence Therapy
NCT07073443
The Effect of Progressive Relaxation Exercise on Adaptation to Old Age and Quality of Life.
NCT04148196
Effect of Reminiscence Therapy on Older Adults
NCT05635058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Baseline data were collected within one week after admission. Then the subject will be followed up for 30 days. Primary outcome was quality of life measured by COOP chart, analyze using on treatment analysis. Secondary outcomes were serum cortisol, interleukin-2, interleukin-6, IFN-ϒ (Interferon gamma), and N Acetyl Aspartat/ creatine ratio in limbic and paralimbic system by Magnetic Resonance Spectroscopy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autosuggestion
Autosuggestion for 30 days
Standard medical theraphy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autosuggestion for 30 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not in steroid therapy
* Could communicate (Karnofsky score: 40% or Zubrod/WHO score: 3)
* Cooperative
* Willing to go through all of the research steps.
Exclusion Criteria
* Multiple Sclerosis
* Brain Tumour
* Using Pace maker
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nina Kemala Sari, MD
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nina K Sari, MD
Role: PRINCIPAL_INVESTIGATOR
Indonesia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Cipto Mangunkusumo Hospital
Jakarta, DKI Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1134-1994
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.